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The aim of this study was to identify markers of training stress and characteristics of middle-23 
distance runners related to the incidence of overreaching following overload training. 24 
Twenty-four highly-trained middle-distance runners (n=16 male; VO2peak=73.3(4.3) 25 
mL·kg·min-1; n=8 female, VO2peak=63.2(3.4) mL·kg·min-1) completed 3 weeks of normal 26 
training (NormTr), 3 weeks of high-volume training (HVTr; a 10, 20 and 30% increase in 27 
training volume each successive week from NormTr), and a 1-week taper (TapTr; 55% 28 
exponential reduction in training volume from HVTr week 3). Before, and immediately after 29 
each training period, an incremental treadmill-running test was performed, while resting 30 
metabolic rate (RMR), subjective fatigue responses and various resting blood biomarkers 31 
were assessed. Muscle fiber typology of the gastrocnemius was estimated by quantification of 32 
muscle carnosine using proton magnetic resonance spectroscopy and expressed as a z-score 33 
relative to a non-athlete control group. Twelve runners were classified as functionally 34 
overreached (FOR) following HVTr (decreased running time to exhaustion; TTE), whereas 35 
the other twelve were classified as acutely fatigued (AF; no decrease in running TTE). The 36 
FOR group did not demonstrate systematic alterations in RMR, resting blood biomarkers or 37 
submaximal exercise responses compared to the AF group. Gastrocnemius carnosine z-score 38 
was significantly higher in FOR (-0.44 ± 0.57) compared to AF (-1.25 ± 0.49, p=0.004, 39 
d=1.53) and was also negatively correlated with changes in running TTE from pre- to post-40 
HVTr (r=-0.55, p=0.005) and pre-HVTr to post-TapTr (r=-0.64, p=0.008). Muscle fiber 41 
typology is related to the incidence of overreaching and performance super-compensation 42 
following increased training volume and a taper.  43 
Keywords: OVERTRAINING; TRAINING LOAD; MUSCLE FIBER TYPE 44 
COMPOSITION; FATIGUE MARKERS; RECOVERY 45 
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New and noteworthy: Variability in the performance responses following an overload 46 
training period and subsequent taper were associated with the variation in the muscle fiber 47 
typology of the gastrocnemius. Runners with an estimated higher proportion of type I fibers 48 
(i.e., lower carnosine z-score) were able to maintain performance in response to an overload 49 
training period and subsequently achieve a superior performance super-compensation. These 50 
findings show that muscle fiber typology contributes to the variability in performance 51 



















A short-term (i.e., days to weeks) decrement in exercise performance induced by overload  68 
training has been termed functional overreaching (FOR), whereby performance restoration (2, 69 
33), and sometimes super-compensation (24, 46), may occur after a recovery period (~1–3 70 
wk) (41, 54). FOR is considered to be a necessary component of a training program to 71 
improve performance in highly-trained athletes  (32, 34, 53, 66). Despite this, recent research 72 
suggests that FOR is associated with disturbed sleep (36, 39, 42, 53), higher incidence of 73 
upper respiratory tract infection (URTI) (36, 75), impaired metabolism (44, 76, 77) and 74 
blunted training and performance adaptations (2, 11, 18) compared to non-overreached 75 
athletes who completed the same relative increase in training load. Thus, clarification of 76 
markers of training stress that may be associated with the onset of FOR is essential to ensure 77 
that the risk of maladaptation to overload training can be mitigated.  78 
Common physiological parameters associated with exercise stress in response to overload 79 
training include heart rate/rhythm derived indices (1, 43, 44, 46), subjective fatigue 80 
perceptions (7, 8, 24, 25, 29, 33, 62, 72), circulating hormone concentrations (24, 31, 47, 59), 81 
markers of inflammation (31), blood lactaemia (44, 73) and resting metabolic rate (RMR) 82 
(76, 77). Unfortunately, few of these parameters have been shown to consistently delineate 83 
between FOR and non-overreached athletes (9), with the possibility that changes simply 84 
reflect general responses to overload training rather than a state of overreaching. 85 
Furthermore, the categorization of overreached subjects in some of these studies was 86 
confounded (59, 72) and not in accordance with the consensus statement defining the 87 
classification of overreaching (53). Recent studies by Woods et al (76, 77) suggest that 88 
reductions in RMR (in both cyclists (77) and rowers (76)) may signal FOR in endurance 89 
athletes in response to increased training load. However, changes in RMR may also be 90 
reflective of a failure to increase energy availability (55) and/or maintain fat free mass (FFM) 91 
Downloaded from journals.physiology.org/journal/jappl at Univ Ziekenhuis (157.193.005.039) on August 21, 2020.
5 
 
(63), rather than a state of overreaching, but this needs further clarification. Recent research 92 
(44, 46) suggests that submaximal (44) and peak heart rate (44) may be reduced, while heart 93 
rate recovery (HRR) may be faster (1, 43) in FOR endurance athletes. However, others have 94 
questioned the discernibility of these heart rate measures to differentiate between FOR and 95 
non-overreached athletes (14, 71). As such, changes in the idiosyncratic physiological 96 
variables associated with FOR require further investigation. 97 
Undertaking a period of overload training (e.g., increases of 30-40% of training volume for 3-98 
4 weeks) does not always result in FOR. Indeed, studies report 33-69% (1, 2, 11, 17, 18, 36, 99 
45, 46, 51) of athletes develop FOR following increases in training volume of this magnitude. 100 
FOR, in some cases (2, 11, 18), is associated with impaired training adaptations and 101 
attenuated performance super-compensation following an overload training period. However, 102 
it must be noted that a number of other studies (23, 24, 33) have also demonstrated a 103 
substantial performance super-compensation following an overload and taper period in 104 
athletes who were classified as being FOR. Why some athletes respond optimally to periods 105 
of overload training, while others do not is currently unknown. One potential explanation 106 
may be related to individual differences in skeletal muscle fiber type composition (i.e., ratio 107 
of type I and type II fibers; muscle fiber typology). Muscle fibers can be identified as pure 108 
(i.e., type I, IIa, IIx) or hybrid fibers that co-express two or more myosin heavy chain 109 
isoforms (i.e., I/IIa, I/IIa/IIx, IIa/IIx, I/IIx) (16). Although type IIa fibers can possess equally 110 
high or even higher mitochondrial volume as type I fibers in endurance trained athletes (19, 111 
57), the cross-bridges (74) and sarcoplasmic reticulum Ca2+ pumps (58) of these fibers 112 
consume more ATP than type I fibers. This would result in a mismatch between the rate of 113 
energy supply and rate of energy use, likely resulting in more pronounced impairments in 114 
sarcoplasmic reticulum Ca2+ release and greater fatigability. In support of this premise, 115 
sarcoplasmic reticulum function is markedly depressed with fatigue in both control subjects 116 
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and trained athletes, and is dependent on fiber type, but appears to be minimally affected by 117 
chronic training status (either endurance or resistance training) (48). As such, trained 118 
individuals with a higher proportion of type II fibers may have greater fatigability (48, 49, 119 
67), take longer time to recover (27, 49) and may adapt optimally to low-volume, high-120 
frequency contractions (40). Conceivably, variation in muscle fiber typology between 121 
individuals may be related to the incidence of overreaching and performance super-122 
compensation in response to increases in training volume, but this remains to be elucidated. 123 
Recently, Baguet et al (3) developed a non-invasive method to estimate muscle fiber 124 
typology, based on the proton magnetic resonance spectroscopy (1H-MRS) derived 125 
measurement of muscle carnosine. This method provides a valid alternative to the invasive 126 
muscle biopsy based on the significant positive correlation (P = 0.009 and r = 0.71) between 127 
the percentage area occupied by type II fibers and muscle carnosine content (3) and the close 128 
level of agreement with the performance characteristics of various athletes (3, 12). More 129 
recent evidence from Lievens et al (49) showed that this non-invasive estimation of muscle 130 
fiber typology strongly influenced the extent of fatigue and time to recover in the acute 131 
period (5 h) following intermittent sprint exercise. However, it remains to be determined 132 
whether the variation in muscle fiber typology between individuals is related to the individual 133 
responses to a long-term period of overload training. 134 
The aim of the present study was to investigate whether 1H-MRS derived measurement of 135 
muscle fiber typology was associated with incidence of overreaching, training-induced 136 
fatigue and performance super-compensation following an overload training period and 137 
subsequent taper. In addition, we monitored various subjective and physiological variables to 138 
provide further clarification on whether these could differentiate between individuals who 139 
show no performance decrease despite high perceived fatigue (i.e., non-overreached) 140 
compared to those who are classified as FOR. We hypothesized that highly-trained middle-141 
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distance runners who have higher muscle carnosine levels (i.e., higher estimated proportion 142 
of type II fibers) may display more severe symptoms of overreaching in response to an 143 
increase in training volume. 144 
METHODOLOGY 145 
Subjects 146 
Twenty-four highly-trained middle-distance runners participated in this study; sixteen males 147 
(age 21.0 ± 3.6 yr, stature 181.3 ± 5.1 cm, body mass (BM) 70.6 ± 7.9 kg, VO2peak 73.3 ± 4.3 148 
mL·kg·min-1) and eight females (mean ± SD: age 21.3 ± 3.2 yr, stature 171.2 ± 4.9 cm, BM 149 
53.1 ± 6.0 kg, maximal oxygen uptake (VO2peak) 63.2 ± 3.4 mL·kg·min-1). Inclusion criteria 150 
specified that subjects were trained specifically for middle-distance races (800 m & 1500 m), 151 
had a consistent training history of at least 2 yr in these events, and were without major injury 152 
interruption for the previous 3 months. Male runners had personal best times for the 800 m 153 
and 1500 m of 119.4 ± 7.8 s (range: 108.3 – 133.4 s) and 238.0 ± 16.8 s (225.2 – 279.1 s), 154 
respectively, while female runners had times of 135.0 ± 8.6 s (124.1 – 153.4 s) and 284.1 ± 155 
18.8 s (257.4 – 321.4 s), respectively. In the 3 weeks preceding the study, mean running 156 
training volume for male and female runners was 73.9 ± 19.2 km·week-1 and 53.9 ± 16.0 157 
km·week-1, respectively. Five females were taking oral contraception, while the other three 158 
reported regular menstrual cycles. All runners provided written informed consent prior to 159 
participating. Ethics approval was granted by the University’s Human Research Ethics 160 
Committee (XXXXXX, removed for peer-review). 161 
General design 162 
The study period lasted 7 weeks, which was divided into three distinct training phases; (1): 3 163 
weeks of normal training (NormTr) prescribed by the runners’ coach, (2): 3 weeks of high-164 
volume training (HVTr; weekly stepwise increase in training volume by 10, 20 and 30% 165 
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during each successive week from NormTr), and (3): a 1-week taper (TapTr; 55% 166 
exponential reduction in training volume from HVTr week 3 (4, 15, 56)). Before, and 167 
immediately after each training phase, runners performed a maximal incremental running test 168 
to determine the gas exchange threshold (GET), respiratory compensation threshold (RCT), 169 
time to exhaustion (TTE), peak heart rate (HRpeak) and VO2peak. A venous blood sample was 170 
collected and body composition, RMR and energy intake were assessed at each time point. 171 
Subjects were scanned by 1H-MRS according to Baguet et al (3) to estimate muscle fiber type 172 
composition of the right gastrocnemius medialis muscle. Subjects were classified as FOR 173 
when their performance in the maximal incremental running test decreased following HVTr 174 
by an amount greater than the smallest meaningful change (SMC) in performance determined 175 
from before and after the NormTr period.  176 
Testing procedures and standardization 177 
Subjects attended the laboratory on five separate occasions; twice before (familiarization and 178 
baseline visit) and once after NormTr, and again after HVTr and TapTr. Subjects were 179 
provided with a standardized dinner (~55 kJ·kg BM-1, 2.0 g carbohydrate·kg BM-1, 0.3 g 180 
fat·kg BM-1, 0.6 g protein·kg BM-1) to consume each evening prior to attending the 181 
laboratory. Subjects presented to the laboratory between 5:00 – 7:30 am after an overnight 182 
fast and refraining from strenuous exercise for at least 40 h. Laboratory conditions were 183 
controlled (22 - 23○C and 45-50% humidity) throughout all tests. During each testing session, 184 
subjects underwent an assessment of RMR and body composition by dual-energy x-ray 185 
absorptiometry (DXA). A fasted venous blood sample was taken from the antecubital vein 186 
following DXA. Subjects were then provided with a standardized breakfast (~40 kJ·kg BM-1, 187 
1.8 g carbohydrate·kg BM-1, 0.2 g fat·kg BM-1, 0.1 g protein·kg BM-1) and rested quietly for 1 188 
h before undertaking submaximal and maximal incremental running tests.  189 
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Resting metabolic rate (RMR) 190 
Indirect measurement of RMR was conducted after 10 min of rest to allow time for 191 
familiarisation and complete relaxation. Subjects were advised to breathe normally and stay 192 
as rested as possible without falling asleep for the duration of the test.  Pulmonary gas-193 
exchange variables (ventilation, VO2, and VCO2) were measured breath-by-breath via an 194 
open-circuit metabolic system (Ultima CardiO2; Medical Graphics Corporation, St. Paul, 195 
MN). To classify steady state, we adopted criteria from Schlein et al (21). In brief, steady-196 
state conditions were established as 30 s mean VO2 and VCO2 coefficient of variation (CV) 197 
values of ≤10% for five consecutive minutes. RMR was reported in absolute (kcal·day−1) and 198 
relative (kcal·kg of fat free mass (FFM)·day−1) terms. Quality control and calibration 199 
procedures were undertaken prior to each test.   200 
Dual-energy x-ray absorptiometry (DXA) 201 
DXA was used to determine whole body bone mineral content, fat and FFM (Medix DR, 202 
Medilink, France). The DXA was calibrated with phantoms in accordance with manufacturer 203 
guidelines each day prior to measurement. All DXA scans were performed and analyzed by 204 
one trained technician, with emphasis on consistency of positioning subjects on the scanning 205 
bed. Scans were analysed automatically by the software, but regions of interest were 206 
subsequently confirmed by the technician. Short-term DXA measurement precision in our lab 207 
is 0.9%, 2.3% and 0.8% for whole body bone mineral content, fat and FFM, respectively. 208 
Submaximal running test 209 
Following a warm-up (5 min at 8 – 10 km·h-1), subjects completed two, 4-min submaximal 210 
incremental stages on a motorised treadmill (HP cosmos Saturn, Traunstein, Germany), 211 
which was set at a speed equivalent to 100% of the GET which was determined in the 212 
familiarisation testing session. The treadmill belt was set at 1% gradient to reflect the 213 
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energetic cost of running overground at these speeds (38). Each of the two stages were 214 
interrupted by a 60-s rest period to allow earlobe blood sampling for determination of blood 215 
lactate concentration ([La]b) with a Lactate Pro 2 device (Arkray inc. Japan). HRR was 216 
assessed during the recovery period following each 4 min stage and reported as the absolute 217 
difference between HR at cessation of the submaximal stage and HR recorded after 60 s of 218 
recovery standing on the treadmill. Pulmonary gas exchange was measured on a breath-by-219 
breath basis throughout each stage using a calibrated metabolic system (Cosmed Quark b2, 220 
Rome, Italy) and rating of perceived exertion (RPE) was measured in the last 30-s period of 221 
each stage.   222 
Maximal incremental running test 223 
Following 5 min of rest after the submaximal running test, each subject performed an 224 
incremental treadmill run to volitional exhaustion; starting at 10 km·h−1 and 1% gradient, 225 
with speed increased by 1 km·h−1 each minute until a speed of 21 km·h−1. After 1 min at 21 226 
km·h−1, the gradient was increased by 1% each minute until volitional exhaustion. RPE was 227 
measured at the end of each stage and gas exchange variables (VO2, VCO2 and expired 228 
ventilation (VE)) were measured (as described for the submaximal exercise test) and 229 
subsequently averaged into 30 s bins. GET was determined using the V-slope method and 230 
RCT was determined using the VE-versus-VCO2 relationship described by Beaver et al, (6). 231 
Two investigators performed threshold determinations independently, and a third investigator 232 
was consulted if any disagreement occurred. HR was recorded each second (H10, Polar 233 
Electro, Oy, Finland) to determine values corresponding to GET, RCT and HRpeak. HRR was 234 
determined from the 60 s of recovery standing on the treadmill directly following the test. 235 
VO2peak was determined as the average of the two highest consecutive 30 s VO2 values, while 236 
TTE was used as a measure of running capacity. [La]b was measured from the earlobe at 1, 3, 237 
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5, and 7 min after completion of the test, with the highest [La]b value obtained at the end of 238 
exercise considered [La]bmax. 239 
Energy intake 240 
To quantify changes in energy intake subjects were asked to keep diet records for three days 241 
prior to each laboratory visit. Specifically, the three days of recording included the two days 242 
immediately prior to the laboratory visit and either a weekend day within that week (to ensure 243 
1 weekend day was included) or the third day prior to the lab visit (if at least one of the three 244 
days fell on a weekend day). The principal investigator met each athlete to provide detailed 245 
instructions on how to accurately record all food/fluid. Subjects were asked to record the time 246 
of intake for all meals, the type of food/fluid (including brand names) and amounts 247 
consumed. To improve validity, food records where EI < 1.39 × RMR were excluded from 248 
the analysis [63]. One member of the research team (JC) analyzed all diet reports using a 249 
dietary analysis software package (FoodWorks 7; Xyris, Queensland, Australia). To assess 250 
inter-rater reliability, an experienced dietitian (CI) also analysed 10% of the diet reports (n = 251 
36). The CV was 4.6% for energy intake, and 5.1% for carbohydrate, 7.1% for protein and 252 
9.3% for fat intakes.   253 
1H-MRS estimation of muscle fiber typology 254 
Muscle carnosine content was measured by 1H-MRS in the soleus and gastrocnemius 255 
medialis muscle of each participant’s right limb in order to estimate muscle fiber typology. 256 
We chose to estimate the muscle fiber typology of the gastrocnemius medialis and soleus 257 
because; i) we can measure carnosine reliably in both of these muscles, ii) carnosine content 258 
in the gastrocnemius medialis muscle has been positively correlated with the percentage area 259 
occupied by type II muscle fibers [49], and; iii) the gastrocnemius medialis and soleus are 260 
very active muscles during running. Indeed, relative to a maximal voluntary contraction, the 261 
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gastrocnemius medialis has the highest mean and maximal electromyographic activity, while 262 
the soleus has the second and third highest, respectively, compared to other prominent lower 263 
limb muscles (70). This suggests that the fiber composition of these muscles may be 264 
meaningful in the context of training induced fatigue and adaptations to running training. 1H-265 
MRS measurements were performed on a 3-T whole body magnetic resonance imaging 266 
(MRI) scanner (Philips Medical Systems, Best, The Netherlands). Subjects were lying in a 267 
supine position, while their lower leg was fixed in a spherical knee-coil. All the spectra were 268 
acquired using single voxel point-resolved spectroscopy (PRESS) with the following 269 
parameters; repetition time (TR) of 2000 ms, echo time (TE) of ~40 ms, number of 270 
excitations was 128 (carnosine) and 16 (water), spectral bandwidth was 2048 Hz, and an 271 
acquisition time of 4 min 16 s (carnosine) and 32 s (water). The voxel size was 40 mm x 15 272 
mm x 20 mm. The voxel location was standardized in the center of the medial portion of both 273 
muscles. The same well-trained and experienced MRI technician (BK) was responsible for 274 
placing the voxel on all scans. The scan for each subject was completed within two weeks 275 
following the post-TapTr testing session. Each subject was scanned in the morning and had 276 
not completed any exercise prior to the scan. Spectral data analysis was carried out using 277 
jMRUI (version 6.0) with carnosine peaks fitted and expressed relative to the internal water 278 
signal 279 
Carnosine content (mM) was calculated using following formula: 280 
  281 
where Cm is the carnosine concentration, CS is the carnosine signal, H2OS is the water signal, 282 
CT1r, CT2r, H2OT1r, H2OT2r are the relaxation correction factors for carnosine (earlier described 283 
by Baguet et al (3)) and water (earlier described by MacMillan et al (52)), H2Omuscle is the 284 
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concentration of water in muscle, which was deducted from the molar concentration of water 285 
(55,000 mM) and the approximate water content of skeletal muscle tissue (0.7 L/kg wet 286 
weight of tissue) and H2Oproton is the number of protons in water. The CV for test-retest inter-287 
day carnosine measurements in our laboratory was 3.5% (soleus) and 4.3% (gastrocnemius; n 288 
= 15 subjects). The carnosine concentration was converted to a muscle- and sex-specific z-289 
score relative to an age-matched control population of active, healthy non-athletes (males: n = 290 
38; females: n = 30).  291 
Training monitoring  292 
To monitor training volume and intensity, each subject wore either an M430 GPS running 293 
watch (n=14; Polar, Kempele, Finland) or a Garmin Forerunner 235 (n = 8; Garmin, Canton 294 
of Schaffhausen, Switzerland) during every running session. Training intensity distribution 295 
was quantified from running speed using the total time-in-zone approach quantified by 296 
training analysis software (TrainingPeaks WEEKO+, Boulder, CO, USA). The percentage of 297 
training time spent with a running speed in each of the three training zones was quantified for 298 
each individual training session. The relative training time in each zone for all sessions was 299 
then determined. The three training zones according to the reference running speed values 300 
that corresponded to physiological thresholds obtained during the maximal running 301 
assessment were used: zone I (<GET), zone II (between GET and RCT) and zone III (>RCT). 302 
Subjects were also provided with a training diary instructing them to rate the global intensity 303 
(RPE; CR-10), volume and duration of all training sessions and races. The 10-point scale was 304 
divided into three training zones based on fixed RPE values with training zone 1 = RPE of 1–305 
4, training zone 2 = RPE of 5–6; and training zone 3 = RPE of 7-10 (61). The total training 306 
time spent with an RPE within each one of these RPE derived training zones was determined. 307 
In addition, session RPE (sRPE) training load was determined by multiplying the intensity of 308 
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each training session by the duration of the session (28). Total weekly load was calculated for 309 
each week by summation of the daily loads. 310 
Wellness and URTI questionnaires  311 
Subjects rated their physical and mental well-being by means of a visual analogue scale 312 
(VAS) as 1–10, with 1 representing the most negative outcome. The questionnaire contained 313 
seven items and was completed at the end of each week throughout the duration of the study. 314 
Items included sleep quality, general mental well-being, general physical well-being, 315 
readiness to train, muscle soreness, fatigue and non-training stress. Subjects also completed 316 
the Wisconsin Upper Respiratory Symptom Survey (WURSS) to assess URTI severity and 317 
symptomatology (5) at the end of each week and were asked to provide their response 318 
relative to that week. The questionnaire included one global question, ten symptom-based 319 
questions and nine functional impairment questions. An overall URTI symptom score was 320 
calculated by summing the URTI severity score (0 = not sick, 1 = very mild URTI to 7 = 321 
severe) from the symptom-based and functional impairment questions (theoretical maximum 322 
score being 133) as proposed by Barrett et al (5). A single incidence of an URTI was defined 323 
as a period during which the weekly total symptom score was ≥21 and separated by 1 wk 324 
from another week with a total symptom score ≥21. 325 
Blood sampling and analysis  326 
Venous blood samples were collected during each of the laboratory visits (pre- and pre-327 
HVTr, post-HVTr and post-TapTr) for determination of various blood biomarkers. Two 10 328 
mL samples were collected into vacutainers containing either ethylenediaminetetraacetic acid 329 
(EDTA) or no anticoagulant (for serum). The EDTA tube was centrifuged immediately for 10 330 
min at 1350 x g, while the serum tube was left to clot for 30 min before being centrifuged. 331 
The resultant samples were stored at -80○C for subsequent analysis. Serum ferritin, iron, total 332 
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iron binding capacity, direct and total bilirubin, total protein, urea, uric acid, lactate 333 
dehydrogenase (LDH), creatinine and C-reactive protein (CRP) were assessed using an 334 
automated clinical chemistry analyser (Au480, Beckman Coulter, Australia) according to the 335 
manufacturer’s instructions for use (IFU). Total vitamin D (25-OH Vitamin D), total and free 336 
T4, total and free T3, thyroid stimulating hormone (TSH), thyroid uptake (i.e. the measure of 337 
the unbound thyroxine binding globulins in the blood), cortisol, testosterone, 338 
dehydroepiandrosterone sulphate (DHEA-S), human growth hormone (hGH) and interleukin 339 
6 (IL-6) were assessed using an automated immunoassay analyser (Access 2, Beckman 340 
Coulter, Australia) according to the manufacturer’s IFU. All parameters were calibrated and 341 
reported acceptable QC values prior to analysis. Testosterone:cortisol ratio and transferrin 342 
saturation were calculated following analytical quantification. A commercially available 343 
ELISA was performed to determine GDF-15. 344 
Assessment of overreaching 345 
In line with previous research (2, 46), the SMC was used as an overreaching threshold which 346 
was calculated as 0.5 × CV of TTE from the incremental running tests performed before and 347 
after NormTr. To be classified as FOR following HVTr, subjects had to report an elevated 348 
subjective fatigue rating following HVTr and show an individual performance decrement 349 
larger than the SMC. The remaining subjects who maintained or increased their performance, 350 
but also showed an elevated subjective fatigue rating following HVTr, were considered to be 351 
acutely fatigued (AF). 352 
Statistical analysis 353 
Results are expressed as mean ± SD unless stated otherwise. A two-way (group and training 354 
phase) analysis of variance (ANOVA) was used to identify differences in performance and 355 
physiological variables between FOR and AF groups. A three-way (group, training phase and 356 
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training zone) ANOVA was used to analyse the training intensity zone distribution data. If a 357 
significant main effect was found, pairwise comparisons were conducted using Tukey post-358 
hoc analysis. Blood biomarker responses were also analysed using an analysis of co-variance 359 
(ANCOVA). The pre-NormTr values were entered into the model as a covariate in order to 360 
account for between-subject variations in blood biomarker levels that may arise from sex-361 
based differences (65) as well as possible differences between naturally menstruating females 362 
and those using oral contraception (13). Regardless of group (FOR and AF), a two-way 363 
repeated measures analysis of variance (ANOVA) with Tukey post-hoc comparisons was 364 
used to compare blood biomarker responses between male and female subjects. The effect 365 
size (d) statistic was also calculated to assess the magnitude of difference between groups. 366 
The magnitude of difference was classified as small 0.2 to 0.59, moderate 0.6 to 1.19, large 367 
1.2 to 1.99, very large 2.0 to 3.99, and extremely large >4.0 (37). All statistical analyses were 368 
performed using SPSS 25.0 (SPSS Inc, Chicago, IL, USA), with statistical significance 369 
accepted as p < 0.05. Test-retest reliability of running TTE, VO2peak and RMR values were 370 
analysed using the CV.  371 
RESULTS 372 
Incidence of overreaching 373 
The CV for initial incremental TTE tests was 6.3%, hence the SMC was considered 3.15%. 374 
Using this criteria, twelve subjects were classified as FOR following HVTr (decreased 375 
running TTE from pre- to post-HVTr), whereas the other twelve subjects were classified as 376 
AF (no decrease in running TTE).  377 
Submaximal and maximal incremental running test  378 
There were no between-group differences in the pre- to post-HVTr change in submaximal 379 
(running speed equivalent to 100% of GET) HR (AF: 2 ± 5 vs. FOR -1 ± 6 beats·min-1), 380 
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[La]b (AF: -0.14 ± 0.58 vs. FOR -0.27 ± 0.61 mmol·L-1), RPE (AF 0.0 ± 0.6 vs. FOR 0.1 ± 381 
0.9 AU; p = 0.70), or HRR (AF -1 ± 5 vs. FOR 2 ± 6 beats·min-1; all p > 0.05) when 382 
measured at a running speed equivalent to 100% of GET.  383 
There was a significant between-group difference for changes in HRR following exhaustive 384 
running (AF = -1 ± 5 vs. FOR 5 ± 5 beats·min-1; p = 0.01; figure 1), as well as the change in 385 
RPE at RCT (AF -0.1 ± 1.4 vs. FOR 1.2 ± 1.6 AU; p = 0.02). Furthermore, HRpeak (-4 ± 3 386 
beats·min-1; p = 0.02) and [La]bmax (-4.30 ± 1.80 mmol·L -1; p = 0.002) were both reduced 387 
from pre-HVTr to post-HVTr in the FOR group compared to the AF group, with both 388 
parameters returning to pre-NormTr values following TapTr (figure 1). Running TTE and 389 
VO2peak did not change across the HVTr period in the AF group (+16 ± 17 s, +1.64 ± 1.80 390 
mL·kg·min-1), while there was a significant decrease in the FOR group (-49 ± 14 s, -2.33 ± 391 
2.20 mL·kg·min-1, p < 0.001). Compared to the FOR group, the AF group had a significantly 392 
larger improvement in TTE from pre-HVTr to post-TapTr (absolute difference score: +37 ± 393 
31 s; p = 0.04), while improvement in VO2peak was similar between groups (AF: +3.52 ± 1.40 394 
mL·kg·min-1; FOR: +2.78 ± 1.80 mL·kg·min-1; p = 0.45). There was no change in the GET 395 
or RCT at any time point for either group.  396 
 Muscle fiber typology 397 
The highly-trained middle-distance runners in the present study predominantly had negative 398 
carnosine z-score values (20/24 runners), suggesting a higher proportion of type I fibers, but 399 
the range was large in both soleus (z-score range: -2.51 to 1.00) and gastrocnemius (-2.02 to 400 
0.46). Gastrocnemius carnosine z-score was significantly higher in FOR (-0.44 ± 0.57; range, 401 
-1.32 – 0.46) compared to AF (-1.25 ± 0.49; -2.02 – -0.47, p = 0.004, d = 1.53; figure 2), but 402 
not soleus carnosine z-score (FOR: -1.03 ± 0.92; -2.51 – 0.44, AF: -1.55 ± 0.93; -2.46 – 1.00, 403 
p = 0.10, d = 0.56). Gastrocnemius carnosine z-score showed a significant negative 404 
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correlation with the change in running TTE from pre-HVTr to post-HVTr (r = -0.55, r2 = -405 
0.31, p = 0.005; figure 3) and pre-HVTr to post-TapTr (r = -0.64, r2 = -0.41, p = 0.008; figure 406 
3). Soleus carnosine z-score was not associated with the change in running TTE from pre-407 
HVTr to post-HVTr (r = -0.21, r2 = -0.04, p = 0.33), but was negatively correlated with the 408 
change in running TTE from pre-HVTr to post-TapTr (r = -0.45, r2 = -0.20, p = 0.013). 409 
RMR, body composition and macronutrient intake 410 
The CV for absolute (MJ·day−1) and relative RMR (kJ·kg·FFM·day−1) was 5.1% and 4.8%, 411 
respectively. No significant time or time × group effect was evident for either absolute or 412 
relative RMR (table 1). Similarly, there was no significant change in BM, body fat 413 
percentage, or FFM in either group throughout the study period (table 1). There was a 414 
significant time effect for relative energy intake for the FOR group, whereby energy intake 415 
during the HVTr period (175 ± 71 kJ·kg·BM·day−1) was greater than both pre-NormTr (148 416 
± 41 kJ·kg·BM·day−1; p = 0.04) and NormTr (140 ± 36 kJ·kg·BM·day−1; p = 0.004) periods. 417 
In the AF group, there was a non-significant 7 ± 18% increase in energy intake during the 418 
HVTr period (160 ± 39 kJ·kg·BM·day−1) compared to the NormTr period (150 ± 17 419 
kJ·kg·BM·day−1; p = 0.62). There were no between group differences at any time point.  420 
Blood parameters  421 
There was no significant time or time x group effect for serum ferritin, iron, total iron binding 422 
capacity, direct and total bilirubin, total protein, urea, uric acid, LDH, creatinine, CRP, total 423 
vitamin D, total and free T4, total and free T3, TSH, thyroid uptake, cortisol, testosterone, 424 
DHEA-S, hGH, GDF-15, IL-6 or the testosterone:cortisol ratio (all p > 0.05; table 2). 425 
Regardless of group (FOR or AF), females had lower levels of ferritin, DHEA-S, LDH, 426 
testosterone and the testosterone:cortisol ratio at each time point compared to males (all p < 427 
0.05).   428 
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Training monitoring  429 
There were no between group differences in training volume at any time point. Training 430 
volume increased from NormTr (3 week mean; FOR 66.2 ± 21.2 km; AF 68.3 ± 19.5 km) 431 
throughout HVTr week 1 (FOR 77.3 ± 24.3 km; AF 75.9 ± 19.6 km), week 2 (FOR 85.9 ± 432 
28.0 km; AF 84.5 ± 19.5 km), and week 3 (FOR 92.9 ± 30.1 km; AF 90.7 ± 19.9 km; all p < 433 
0.001), and was reduced during TapTr (FOR 43.2 ± 13.5 km; AF 42.1 ± 9.9 km; p < 0.001; 434 
table 3). There were no between group changes, nor was there a time effect on the running 435 
speed derived training intensity distribution (table 5). In contrast, the RPE derived training 436 
intensity distribution was altered during the third week of HVTr, whereby the FOR group 437 
spent a significantly greater time in zone 3 and reduced time in zone 1 (zone 1: 28.2 ± 4.8%, 438 
zone 2: 33.1 ± 6.2%, zone 3: 38.7 ± 3.8%) compared to each week of NormTr (all p < 0.05), 439 
the first week of HVTr (zone 1: 35.7 ± 6.5%; p = 0.01, zone 2: 35.9 ± 7.5%, zone 3: 28.4 ± 440 
9.5%; p = 0.004) and TapTr (zone 1: 36.2 ± 8.1%; p = 0.006, zone 2: 34.7 ± 5.9%, zone 3: 441 
29.1 ± 9.2%; p = 0.009). Conversely, there was no change in the RPE derived training 442 
intensity distribution in the AF group (p > 0.05).  443 
Wellness questionnaires 444 
There were no significant group × time interactions between AF and FOR for any items of 445 
the wellness questionnaire. Regardless of group, participants reported reductions in physical 446 
well-being, readiness to train and mood, as well as increased muscle soreness and fatigue 447 
following week two and three of HVTr (table 4). There was a significant effect of time for 448 
reductions in perceived sleep quality that were only evident in the FOR group after the 449 
second (5.6 ± 2.0 AU; p = 0.009) and third week of HVTr (5.4 ± 1.5 AU; p = 0.004), which 450 
returned to NormTr levels (7.7 ± 1.0 AU) after TapTr (7.8 ± 1.2 AU). During HVTr, seven 451 
subjects reported at least one episode of URTI, with five of these occurring from subjects in 452 
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the FOR group. There was a significant time effect in the FOR group for URTI symptom 453 
score following the third week of HVTr (27.5 ± 36.8, p = 0.002). 454 
DISCUSSION 455 
In the present study, we have shown that 1H-MRS derived measurement of muscle fiber 456 
typology is associated with incidence of FOR following a period of overload training and 457 
performance super-compensation following a taper. That is, trained middle-distance runners 458 
who became FOR had a higher gastrocnemius carnosine z-score (estimated to have a higher 459 
proportion of type II fibers) compared to those that were non-overreached following a period 460 
of overload training, while FOR also had a reduced performance super-compensation 461 
following a subsequent taper period. We also show that FOR is not associated with 462 
systematic alterations in absolute or relative RMR, resting blood biomarkers, subjective 463 
fatigue questionnaire ratings or submaximal exercise responses.  464 
The incidence of FOR following HVTr observed in the present study (12/24 runners), is in 465 
agreement with rates reported in other studies employing similar overload training periods 466 
(i.e., increases of 30-40% of training volume for 3-4 weeks) (2, 36, 46, 51). The magnitude of 467 
change in running capacity following HVTr (mean change: -16 ± 43 s, range: -120 to 65 s) 468 
and TapTr (mean change: +38 ± 35 s, range: -20 to 120 s) was highly variable. Variation in 469 
the individual muscle carnosine z-score values in the gastrocnemius did explain a significant 470 
magnitude of the variability in the performance responses following HVTr and TapTr, 471 
relative to pre-HVTr. Runners with an estimated higher proportion of type I fibers (i.e., lower 472 
carnosine z-score) were able to maintain performance in response to overload training and 473 
obtained a superior performance super-compensation following the taper. These findings 474 
suggest that runners with an estimated higher proportion of type-I fibers are able to better 475 
cope with increases in training volume and achieve superior performance adaptations. While 476 
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type II fibers can possess equally high or even higher mitochondrial volume as type I fibers in 477 
endurance trained athletes (19, 57), differences in cross-bridge (74) and sarcoplasmic 478 
reticulum Ca2+ pump ATP consumption (58) may result in greater fatigability (48, 49, 67), 479 
delayed recovery (27, 49) in type II fibers. Conversely, type I fibers are fatigue resistant (35), 480 
but may adapt optimally to low frequency, higher-volume contractions (60). Conceivably, 481 
individuals with a high proportion of type I fibers may therefore adapt more favourably to 482 
increases in training volume. On the other hand, individuals with a high proportion of type II 483 
fibers may develop greater residual fatigue from increased training volume and suboptimal 484 
adaptations in these fibers, resulting in impaired performance and a higher incidence of FOR. 485 
Indeed, short-term overload training can reduce type II fiber size (27), while improvements in 486 
maximal shortening velocity appears to be resigned to type I fibers, (27, 68). More recent 487 
work from Lievens et al (49) reported that the 1H-MRS derived measurement of muscle fiber 488 
typology of the gastrocnemius was associated with the magnitude of fatigue within an 489 
intermittent sprint exercise session, as well as the recovery timeline in a well-controlled 5-h 490 
recovery period. Individuals classified as having fast-twitch typology had still not fully 491 
recovered maximal voluntary torque production of the knee extensors after 5 h of recovery, 492 
while those with slow-twitch typology had fully recovered after 20 min (49). Collectively, 493 
these findings (27, 49, 68) lead to the hypothesis that both acute and longer-term periods of 494 
overload training may result in residual fatigue possibly due to impairments in the contractile 495 
properties of type II fibers leading to impaired exercise performance, which may provide 496 
mechanistic evidence supporting the findings of the present study. Given that the runners in 497 
the present study classified as FOR had higher gastrocnemius carnosine z-score values (and 498 
presumably a higher proportion of type II fibers) compared to the AF group, it may be that 499 
the functional characteristics of these fibers were impaired by the HVTr period, leading to 500 
impaired running performance following the overload period. While soleus carnosine z-score 501 
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was significantly negatively correlated with the change in running TTE from pre-HVTr to 502 
post-TapTr, the associations between gastrocnemius carnosine z-score and the change in 503 
running TTE across both the HVTr and TapTr period were stronger compared to the soleus.  504 
While both the soleus and gastrocnemius have very high levels of relative muscle activation 505 
during running compared to other major lower limb muscles (70), it may be that the absolute 506 
contribution of the gastrocnemius muscle to ground reaction force during running is more 507 
influential than the soleus. Thus, the fiber type composition of the gastrocnemius may be 508 
more meaningful in the context of training induced fatigue and adaptations to running 509 
training compared to the soleus. 510 
In the present study, each week of HVTr was completed with the same weekly distribution, 511 
type, and content of running training sessions as the corresponding week in NormTr but with 512 
the prescribed increased volume (i.e., +10-30%). While there were no between group 513 
differences in the total training volume (duration or distance covered), or the running speed 514 
derived training intensity distribution, subjects’ perceptions of the training differed. During 515 
the third week of HVTr, the FOR group perceived more of the training sessions to have an 516 
RPE >6; thus, accumulating more time in training zone 3 using the RPE derived training 517 
intensity distribution. This also resulted in a significantly larger sRPE training load during the 518 
third week of HVTr compared to the AF group. While previous research indicates that the 519 
method of training-intensity quantification substantially affects computation of training 520 
intensity distribution (10), this is the first study to show clear delineation in training intensity 521 
distribution computed from two different measures of training intensity (external work rate 522 
and perceived intensity) in response to alterations in training volume. This is also supported 523 
by observations of significantly greater RPE at running speeds equivalent to the RCT in the 524 
FOR compared to AF group following HVTr. As such, runners in the FOR group perceived 525 
the intensity of running at speeds approximating the RCT to be substantially higher and 526 
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training sessions that incorporated similar running speeds were perceived to be more intense, 527 
particularly during the third week of HVTr. While the running speed derived training 528 
intensity distribution suggests that training intensity was not hampered during HVTr (i.e., 529 
similar time in zone 3 throughout the study), one limitation of the 3-zone training model is 530 
that the third training zone includes all the training time accumulated with a running speed 531 
greater than the speed equivalent to RCT. Given this spans a range of physiological and 532 
mechanical characteristics (i.e., RCT to maximal sprinting speed), it may reduce the 533 
sensitivity of detecting small decrements in running speed during training, where repetitions 534 
may be completed at a running speed >RCT.  535 
With the exception of a higher RPE at a running speed equivalent to RCT, other 536 
physiological responses to submaximal exercise were unable to differentiate between FOR 537 
and non-overreached participants in the present study. In contrast, reductions in VO2peak, 538 
HRpeak, [La]bmax and faster HRR during exhaustive running were greater in the FOR group 539 
compared to the AF group. These findings are in agreement with previous literature reporting 540 
reductions in VO2peak, HRpeak, and [La]bmax (14, 44) and faster HRR (1, 43) in FOR athletes. 541 
However, these studies have also typically observed altered physiological responses during 542 
submaximal exercise, but it should be noted that this is not a universal finding. Indeed, 543 
Bellenger et al (8) suggests that HRR is only sensitive to changes in training status when 544 
assessed after maximal exercise. Nonetheless, a key sentiment based on findings from the 545 
present study and previous work (1, 8, 14, 43, 44), is that multiple physiological variables 546 
should be measured to monitor fatigue associated with training; and changes in these 547 
variables should be interpreted in the context of the specific training phase. 548 
In the present study, both groups reported adverse effects based on changes to the majority of 549 
subjective weekly wellness responses. However, only the FOR group reported impairments in 550 
sleep quality (i.e., during the second and third week of HVTr) as well as higher URTI 551 
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symptom scores and URTI incidence in week 3 of HVTr. In addition, the FOR group had 552 
moderately higher effect size differences (despite not being significant) in subjective fatigue 553 
ratings after the first and second week of HVTr. These findings are consistent with previous 554 
literature reporting impaired sleep and increased susceptibility to infection in overreached 555 
endurance athletes (36) and exacerbated subjective fatigue ratings in athletes who become 556 
FOR (1, 2, 36, 45). More recently, Ten Haaf (72) demonstrated that the combination of 557 
changes in subjective fatigue and readiness to train after only 3 days of a cycling tour 558 
correctly predicted 78% of the participants as either FOR or not using simple visual analogue 559 
scales. However, despite not being significantly different, there was still a large reduction in 560 
incremental cycling test peak power output in the FOR group approximately one month 561 
following the cycling event which may indicate that at least some of these participants were 562 
NFOR and not FOR (72). Nonetheless, while there is some evidence (1, 2, 36, 45) that 563 
subjective questionnaires can differentiate between athletes who are FOR and not following 564 
an overload training period, more research is needed to determine if these responses manifest 565 
prior to a decrement in exercise performance. 566 
Changes to a number of blood biomarkers have been associated with overload training 567 
responses (31), but few have consistently been shown to differentiate between FOR and non-568 
overreached athletes. The present study involved quantifying the change to a range of blood 569 
biomarkers, reflecting inflammation (IL-6 and CRP), metabolism (GDF15, thyroid 570 
hormones), catabolic and anabolic biomarkers (DHEA-S, urea, total protein, testosterone, 571 
cortisol and GH), muscle damage (lactate dehydrogenase), kidney function (creatinine) and 572 
iron regulation (iron, ferritin and UIBC) relative to overload training responses. We failed to 573 
observe any parameter (measured at rest) that was able to differentiate between FOR and 574 
non-overreached athletes. These results are in agreement with Lehmann et al (47) who found 575 
no significant changes in thyroid hormones in middle- and long-distance runners following a 576 
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two-fold increase in training volume. Previous research in cyclists and triathletes who were 577 
classified as FOR also indicated no changes in various hormone levels (testosterone, cortisol 578 
and growth hormone) (73). Likewise, changes in urea and markers of iron regulation do not 579 
appear to differentiate FOR and non-overreached athletes (22). Taken collectively, no resting 580 
blood biomarkers have been established as a sensitive predictor of FOR in endurance athletes.   581 
Recently, GDF15 has been identified as a potential blood biomarker of overreaching (59). 582 
GDF15 is thought to be a stress-responsive biomarker related to the regulation of 583 
inflammatory processes (26), as well as appetite regulation (69) and bone metabolism (59). 584 
Poffe et al (59) substantially increased the training load of male subjects for 3 weeks and 585 
observed increased systemic levels of GDF15 in subjects who consumed a placebo drink 586 
(~292 ± 19 pg·ml-1 to 435 ± 29 pg·ml-1). Results of the present study differ from those of 587 
Poffe et al (59), whereby we found no significant differences in systemic levels of GDF15 588 
post-HVTr in both the FOR and AF groups. Several explanations for the contrasting findings 589 
may exist. For instance, the training status of subjects (healthy, non-specifically trained males 590 
vs highly-trained middle-distance runners), the nature of the overload training period (3-fold 591 
increase vs 10-30% increase) and the absolute levels of GDF15 (pre-training baseline: ~280 592 
pg·mL-1 vs 541 pg·mL-1), whereby the post-overload training GDF15 values reported in the 593 
male subjects of Poffe et al (59) (placebo group: 435 ± 29 pg·ml-1) were still lower than the 594 
pre-NormTr levels of the highly-trained runners in the present study. It is possible that 595 
GDF15 concentrations may provide a general marker of training-induced physiological stress 596 
associated with the high training volume (67.1 ± 20.4 km·wk-1) and frequency (6-8 running 597 
sessions·wk-1) employed by the athletes in the present study. This suggests GDF15 may not 598 
be a sensitive marker to diagnose development of overreaching in trained athletes. 599 
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In the present study, we did not observe alterations in RMR in response to HVTr or TapTr. 600 
This finding contrasts that of two recent studies reporting a reduction in RMR with increased 601 
training load in well-trained endurance athletes (76, 77). The mechanism behind the reduced 602 
RMR in the previous studies (76, 77) is unclear. It is possible that the increased energetic 603 
demands of training, coupled with insufficient energy intake, are contributing factors. Indeed, 604 
despite a 21% increase in training load, participants in the study by Woods et al (76) did not 605 
increase their total energy or macronutrient intake, while trained cyclists in the study by 606 
Woods et al (77) had a significant reduction in FFM. Given that FFM (63) and energy 607 
availability (55) are major determinants of RMR, failure to increase energy intake and/or 608 
preserve FFM in response to increases in training load may be responsible for the reductions 609 
in RMR evident in these studies (76, 77). In the present study, the FOR group increased 610 
energy intake during the HVTr period (175 ± 71 kJ·kg·BM·day−1) compared to pre-NormTr 611 
(148 ± 41 kJ·kg·BM·day−1) and NormTr (140 ± 36 kJ·kg·BM·day−1). The AF group had a 612 
non-significant increase in energy intake during the HVTr period (160 ± 39 kJ·kg·BM·day−1) 613 
compared to pre-NormTr (149 ± 17 kJ·kg·BM·day−1) and NormTr (150 ± 17 614 
kJ·kg·BM·day−1), while BM and FFM were preserved in both groups. As such, a reduction in 615 
RMR is not likely to be indicative of a given fatigue-induced training state per se (i.e., FOR), 616 
rather a reflection of an individual’s inability to compensate for increases in training load by 617 
increasing energy intake.  618 
A strength of the present study is the comprehensive attainment of data on energy availability 619 
before and after each training phase (i.e., energy intake, RMR and body composition) as well 620 
as pre-testing dietary standardization (evening meal and breakfast). Estimates of EI rely on 621 
the notoriously difficult task of gaining valid and reliable information about an athlete’s 622 
habitual dietary intake by self-reporting which is prone to errors of underreporting (20). As 623 
such, we were only able to consider diet reports for 16 of the 24 subjects as eight subjects 624 
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(FOR = 4; AF = 4) were identified as having implausible food records (30). The taper 625 
characteristics in the present study are in line with recommendations based on a meta-626 
analysis (15), modelling (4) and experimental studies (56) suggesting that a ~50% reduction 627 
in training volume in an exponential decay fashion over a period of 1 – 2 week can elicit peak 628 
performance improvements in endurance athletes. Despite this, it would have also been 629 
intriguing to extend our taper period beyond 1 wk, given the longer recovery time course of 630 
type II fibers  (27, 50). It is likely that an optimal taper period should be individualised for 631 
each athlete (64), and it has been suggested that longer taper periods may be required 632 
following an overload training period due to greater stress and fatigue (66). Future research 633 
should investigate whether tapering strategies could be optimised by considering the muscle 634 
fiber typology of endurance athletes. Finally, the direct measurement of muscle fiber 635 
typology derived from a muscle biopsy may have provided further insight into the 636 
relationships between pure and hybrid fibers and the performance and physiological 637 
responses to alterations in training volume. 638 
The main findings of the present study were that highly-trained middle-distance runners who 639 
became FOR following a period of overload training had a substantially higher gastrocnemius 640 
carnosine z-score (higher estimated proportion of type II fibers) and a reduced performance 641 
super-compensation following a subsequent taper period, compared to runners with a lower 642 
gastrocnemius carnosine z-score. We also showed that FOR was associated with altered 643 
perceptual responses to training but there were no systematic changes in RMR, resting blood 644 
biomarkers or submaximal exercise responses compared to runners who did not demonstrate 645 
impaired performance. These findings may have important applications in the development of 646 
individualized training advice and the monitoring of training load for endurance athletes 647 
undertaking overload training periods. More specifically, athletes with lower gastrocnemius 648 
carnosine Z-score values may have more favourable responses to periods of overload training 649 
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and a subsequent taper. This non-invasive estimation of muscle fiber typology could be used 650 
a tool to a priori identify which athletes may be more likely to respond favourably to a 651 
training volume overload period. 652 
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 882 
FIGURES: 883 
Figure 1 – Mean (95% confidence intervals) of time to exhaustion (A), VO2peak (B) peak 884 
blood lactate concentration (C), peak heart rate (D) and heart rate recovery (E) measured 885 
before NormTr, before and after HVTr and after TapTr for the FOR group and AF group (n = 886 
12 per group). A two-way (group and training phase) ANOVA with Tukey post-hoc analysis 887 
was used. 888 
aSignificantly different compared to pre-NormTr, pre-HVTr and post-TapTr  889 
bSignificant difference between FOR and AF 890 
cSignificantly different compared to pre-NormTr and pre-HVTr  891 
 892 
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Figure 2 – Mean (95% confidence intervals) of the training intensity distribution, quantified 893 
as the percentage of total time spent in each of the three training zones based on running 894 
speed for the AF group (A) and FOR group (B) and based on rating of perceived exertion 895 
with AF group (C) and FOR group (D) during NormTr, HVTr (week 1, 2 and 3) and TapTr (n 896 
= 12 per group). A three-way (group, training phase and training zone) ANOVA with Tukey 897 
post-hoc analysis was used. 898 
aSignificantly different compared to NormTr, HVTr week 1 and TapTr  899 
bSignificantly different compared to NormTr, HVTr week 1 and TapTr 900 
 901 
Figure 3 – Mean (95% confidence interval) of the gastrocnemius carnosine z-score of the AF 902 
and FOR group (n = 12 per group). A one-way ANOVA was used. 903 
aSignificant difference between FOR and AF 904 
 905 
Figure 4 – Association between 1H-MRS estimation of muscle fiber typology (gastrocnemius 906 
carnosine z-score) and the relative change in time to exhaustion from pre- to post-HVTr (A) 907 
and pre-HVTr to post-TapTr (B). Shaded area represents the smallest meaningful change 908 
(half the CV%). Linear regression was used and all subjects were included in the analysis 909 
regardless of group (i.e., FOR and AF; n = 24 in total). 910 
 911 
TABLES: 912 
Table 1 - Mean (SD) values for body composition, resting metabolic rate and macronutrient 913 
and energy intake measured before and after NormTr, and after the HVTr and TapTr period 914 
for the FOR group and AF group. 915 
NormTr: normal training period, HVTr: high-volume training period, TapTr: taper training 916 
period, RMR: resting metabolic rate, FFM: fat-free mass, FOR: functional overreaching, AF: 917 
acutely fatigued  918 
aSignificantly different compared to pre-NormTr, pre-HVTr and post-TapTr 919 
 920 
Table 2 - Mean (SD) values for subjective wellness questionnaire responses and upper 921 
respiratory tract infection symptom score and occurrences measured during each training 922 
phase for the FOR group and AF group. 923 
NormTr: normal training period, HVTr: high-volume training period, TapTr: taper training 924 
period, URTI: upper respiratory tract infection, FOR: functional overreaching, AF: acutely 925 
fatigued 926 
aSignificantly different compared to each week of NormTr and TapTr. bSignificant difference 927 
between groups 928 
 929 
Table 3 - Mean (SD) values for weekly training duration, volume, load and distribution of 930 
training intensity during each training phase for the FOR group and AF group. 931 
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NormTr: normal training period, HVTr: high-volume training period, TapTr: taper training 932 
period, RPE: rating of perceived exertion, sRPE: session RPE training load, TID: training 933 
intensity distribution, FOR: functional overreaching, AF: acutely fatigued 934 
asignificantly different compared to each week of NormTr and TapTr 935 
bsignificantly different compared to each week of NormTr, HVTr week 1 and TapTr 936 
csignificantly different compared to each week of NormTr, HVTr week 1 and 2 and TapTr 937 
dsignificantly different compared to each week of NormTr and HVTr  938 
drelative training time in zone 3 significantly different compared to each week of NormTr, 939 
HVTr week 1 and TapTr  940 
drelative training time in zone 3 significantly different compared to each week of NormTr, 941 
HVTr week 1 and TapTr  942 
 943 
Table 4 - Mean (SD) values for the blood biomarkers measured before and after NormTr, and 944 
after the HVTr and TapTr period for the FOR group and AF group. 945 
NormTr: normal training period, HVTr: high-volume training period, TapTr: taper training 946 
period, TIBC: total iron-binding capacity, UIBC: Unsaturated iron-binding capacity, VitdA: 947 
vitamin D (total 25(OH)D), GDF15: growth differentiation factor-15, FT3: free 948 
triiodothyronine, FT4: free thyroxine, TotT3: total triiodothyronine, TotT4: total thyroxine, 949 
TSH: thyroid stimulating hormone, TU: thyroid uptake, DHEA-S: dehydroepiandrosterone 950 
sulphate, hGH: human growth hormone, CRP: C-reactive protein, IL-6: interleukin-6, LDH: 951 
lactate dehydrogenase 952 
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Table 1 - Mean (SD) values for body composition, resting metabolic rate and macronutrient 
and energy intake measured before and after NormTr, and after the HVTr and TapTr period 




Pre-HVTr Post-HVTr Post-TapTr 
Body mass (kg) 
AF 67.5 ± 10.4 68.0 ± 10.9 67.4 ± 11.1 67.6 ± 10.7 
FOR 62.9 ± 9.2 62.8 ± 9.3 62.7 ± 9.4 62.5 ± 9.7 
Lean body mass (kg) 
AF 54.5 ± 9.44 54.9 ± 9.78 54.5 ± 9.96 54.5 ± 9.48 
FOR 50.7 ± 8.14 50.6 ± 8.16 50.6 ± 8.10 50.5 ± 8.41 
Bone mineral content (kg) 
AF 3.25 ± 0.42 3.29 ± 0.44 3.35 ± 0.45 3.30 ± 0.45 
FOR 3.19 ± 0.43 3.22 ± 0.43 3.23 ± 0.44 3.22 ± 0.44 
Fat mass (kg) 
AF 9.75 ± 1.94 9.88 ± 1.96 9.51 ± 1.98 9.71 ± 1.97 
FOR 9.10 ± 0.96 8.97 ± 1.22 8.84 ± 1.24 8.72 ± 1.23 
Body fat parentage (%) 
AF 14.6 ± 1.61 14.7 ± 2.81 14.2 ± 2.83 14.6 ± 2.79 
FOR 14.6 ± 1.54 14.4 ± 1.70 14.2 ± 1.52 14.0 ± 1.45 
Absolute RMR (MJꞏday−1) 
AF 6.86 ± 1.23 6.57 ± 1.07 6.81 ± 1.28 6.69 ± 1.32 
FOR 7.01 ± 0.91 7.15 ± 1.33 6.85 ± 1.08 6.58 ± 1.18 
Relative RMR (kJꞏkg 
FFMꞏday−1) 
AF 127.7 ± 11.6 121.9 ± 10.3 125.9 ± 14.4 123.4 ± 10.5 
FOR 122.9 ± 15.8 124.2 ± 13.7 119.5 ± 9.3 115.0 ± 13.9 
Energy intake (kJꞏkgꞏday−1) 
AF 148.6 ± 17.4 149.6 ± 16.7 160.0 ± 39.5 144.7 ± 20.7 
FOR 148.5 ± 41.3 140.5 ± 36.4 174.6 ± 71.2a 156.5 ± 58.2 
Carbohydrate intake (gꞏkg 
BMꞏday−1) 
AF 3.96 ± 0.49 3.86 ± 0.53 4.33 ± 1.10 3.41 ± 1.17 
FOR 3.89 ± 1.37 3.77 ± 1.25 4.47 ± 2.47 4.16 ± 1.64 
Protein intake (gꞏkg 
BMꞏday−1) 
AF 1.54 ± 0.27 1.62 ± 0.39 1.73 ± 0.44 1.44 ± 0.23 
FOR 1.41 ± 0.47 1.49 ± 0.26 1.92 ± 0.61a 1.52 ± 0.50 
Fat intake (gꞏkg BMꞏday−1) 
AF 1.40 ± 0.23 1.45 ± 0.28 1.44 ± 0.47 1.40 ± 0.37 
FOR 1.51 ± 0.41 1.32 ± 0.37 1.63 ± 0.57 1.51 ± 0.65 
NormTr: normal training period, HVTr: high-volume training period, TapTr: taper training 
period, RMR: resting metabolic rate, FFM: fat-free mass, FOR: functional overreaching, AF: 
acutely fatigued  
aSignificantly different compared to pre-NormTr, pre-HVTr and post-TapTr 
 
Downloaded from journals.physiology.org/journal/jappl at Univ Ziekenhuis (157.193.005.039) on August 21, 2020.
Table 2 - Mean (SD) values for subjective wellness questionnaire responses and upper respiratory tract infection symptom score and 
occurrences measured during each training phase for the FOR group and AF group. 
     NormTr   HVTr  TapTr 
    1 2 3 1 2 3 1 
Sleep quality FOR 7.7 ± 1.0 7.6 ± 1.2 7.8 ± 1.1 6.2 ± 1.8 5.6 ± 2.0
a 5.4 ± 1.5a 7.8 ± 1.2 
AF 7.0 ± 2.0 6.6 ± 1.8 6.8 ± 1.4 6.8 ± 1.6 6.1 ± 2.3 6.1 ± 2.1 6.8 ± 1.3 
Physical well-
being 
FOR 7.4 ± 1.9 7.2 ± 1.8 7.3 ± 1.8 6.0 ± 1.4 5.8 ± 1.5
a 5.3 ± 2.1a 7.9 ± 1.2 
AF 7.3 ± 1.4 7.2 ± 1.1 7.3 ± 1.4 5.9 ± 1.6 5.7 ± 1.9a 6.1 ± 1.3 7.5 ± 0.6 
Readiness to 
train 
FOR 7.9 ± 1.2 7.4 ± 1.7 7.3 ± 1.8 5.9 ± 2.1a 5.8 ± 1.9a 3.7 ± 1.8a 8.3 ± 1.2 
AF 7.6 ± 1.4 7.6 ± 1.5 7.8 ± 1.4 5.8 ± 2.7
a 5.9 ± 2.4a 5.0 ± 2.3a 7.8 ± 1.0 
Muscle 
soreness 
FOR 2.5 ± 1.5 3.0 ± 2.1 3.1 ± 2.0 5.4 ± 1.7a 5.4 ± 1.6a 6.2 ± 2.0a 3.7 ± 2.4 
AF 3.0 ± 1.5 2.8 ± 1.8 2.7 ± 1.3 4.9 ± 1.1a 5.2 ± 1.6a 5.7 ± 1.4a 4.0 ± 1.5 
Fatigue FOR 
3.2 ± 1.3 3.6 ± 1.9 4.2 ± 1.3 5.6 ± 1.4a 6.4 ± 1.3a 6.8 ± 1.5a 4.7 ± 2.3 
AF 3.7 ± 1.4 4.4 ± 1.6 4.3 ± 1.5 5.3 ± 2.3 5.8 ± 2.6
a 5.7 ± 2.7a 3.9 ± 1.4 
Non-training 
stress 
FOR 2.8 ± 2.4 2.9 ± 2.5 2.8 ± 1.3 3.0 ± 1.8 2.7 ± 2.1 2.7 ± 1.5 2.4 ± 0.9 
AF 2.4 ± 1.9 2.7 ± 1.2 3.7 ± 1.9 3.8 ± 2.7 2.8 ± 1.8 2.7 ± 2.1 2.8 ± 1.8 
Mood FOR 
7.9 ± 0.9 7.6 ± 1.1 7.3 ± 1.5 5.6 ± 1.3a 5.0 ± 1.6a 4.4 ± 1.1a 7.3 ± 1.4 
AF 7.7 ± 1.7 7.7 ± 1.6 6.9 ± 1.9 5.4 ± 1.5
b 5.0 ± 2.1a 5.2 ± 2.2a 7.0 ± 0.9 
URTI symptom 
score 
FOR 2.9 ± 3.8 2.8 ± 4.9 4.3 ± 9.5 2.3 ± 2.9 17.1 ± 24.4 27.5 ± 36.8
ab 3.8 ± 4.7 
AF 7.0 ± 13.4 3.0 ± 3.2 3.0 ± 3.2 7.7 ± 8.0 7.5 ± 11.2 8.5 ± 17.4 1.8 ± 3.7 
URTI 
occurrence  
FOR 0 0 0 0 2 3 0 
AF 1 0 0 1 1 0 0 
NormTr: normal training period, HVTr: high-volume training period, TapTr: taper training period, URTI: upper respiratory tract infection 
aSignificantly different compared to each week of NormTr and TapTr 
bSignificant difference between groups 
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Table 3 - Mean (SD) values for weekly training duration, volume, load and distribution of training intensity during each training phase for the 
FOR group and AF group. 
     NormTr   HVTr  TapTr 
    1 2 3 4 5 6 7 
Weekly running training 
volume (min) 
FOR 359 ± 38 362 ± 40 367 ± 40 396 ± 43a 442 ± 56b 481 ± 62c 226 ± 42d 
AF 355 ± 60 365 ± 65 362 ± 69 389 ± 72a 437 ± 70b 473 ± 64c 225 ± 2d 
Weekly running training 
volume (km) 
FOR 68.3 ± 18.9 68.6 ± 21.1 67.8 ± 20.3 75.9 ± 19.6a 84.5 ± 19.4b 90.7 ± 19.9c 42.1 ± 9.9d 
AF 70.3 ± 23.3 71.3 ± 21.8 71.6 ± 23.2 77.3 ± 24.3a 85.9 ± 28.0b 92.9 ± 30.1c 43.2 ± 13.5d 
sRPE (AU) FOR 
1779 ± 258 1804 ± 258 1800 ± 51 1967 ± 276a 2299 ± 295b 2613 ± 393c 1130 ± 274d 
AF 1731 ± 334 1816 ± 333 1784 ± 381 1917 ± 386a 2160 ± 383b 2337 ± 341c 1103 ± 122d 
Running speed derived TID 
(% training time in zone 
1/2/3) 
FOR 80/5/15 81/6/13 80/6/14 79/7/14 80/6/14 80/7/13 80/5/15 
AF 82/5/13 80/6/14 81/5/14 81/6/13 82/5/13 80/6/14 83/6/11 
RPE derived TID (% 
training time in zone 1/2/3) 
FOR 36/36/28 35/37/28 36/37/27 36/36/28 33/35/32 28/33/39e,f 36/35/29 
AF 39/32/29 36/35/29 36/35/29 37/35/28 36/36/28 36/36/28 38/34/26 
NormTr: normal training period, HVTr: high-volume training period, TapTr: taper training period, RPE: rating of perceived exertion, sRPE: 
session RPE training load, TID: training intensity distribution 
asignificantly different compared to each week of NormTr and TapTr 
bsignificantly different compared to each week of NormTr, HVTr week 1 and TapTr 
csignificantly different compared to each week of NormTr, HVTr week 1 and 2 and TapTr 
dsignificantly different compared to each week of NormTr and HVTr  
drelative training time in zone 3 significantly different compared to each week of NormTr, HVTr week 1 and TapTr  
drelative training time in zone 3 significantly different compared to each week of NormTr, HVTr week 1 and TapTr  
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Table 4 - Mean (SD) values for the blood biomarkers measured before and after NormTr, and 




Pre-HVTr Post-HVTr Post-TapTr 
Ferritin (ug/L) 
FOR 55.9 ± 32.9 54.7 ± 26.3 49.4 ± 31.2 46.7 ± 26.3 
AF 62.3 ± 37.4 65.7 ± 39.0 60.3 ± 35.4 60.2 ± 29.3 
Iron (umol/L) 
FOR 20.5 ± 7.8 16.6 ± 6.1 19.7 ± 10.2 16.0 ± 6.8 
AF 18.8 ± 5.6 17.9 ± 5.6 18.3 ± 7.5 22.6 ± 12.6 
TIBC (umol/L) 
FOR 56.0 ± 8.9 57.1 ± 10.9 59.6 ± 9.6 56.8 ± 5.9 
AF 56.4 ± 8.0 60.4 ± 7.3 60.3 ± 6.8 64.9 ± 12.3 
Transferrin saturation 
(%) 
FOR 36.6 ± 14.0 29.7 ± 10.5 32.7 ± 13.1 27.9 ± 9.7 
AF 33.6 ± 9.6 36.1 ± 21.6 30.5 ± 12.1 35.1 ± 20.6 
Total protein (g/L) 
FOR 68.2 ± 5.5 68.5 ± 5.3 69.8 ± 7.1 67.3 ± 4.97 
AF 64.8 ± 9.7 68.9 ± 4.33 68.0 ± 6.0 73.3 ± 12.7 
UIBC (umol/L) 
FOR 1.20 ± 0.28 1.18 ± 0.28 1.13 ± 0.22 1.09 ± 0.30 
AF 1.33 ± 0.30 1.36 ± 0.46 1.34 ± 0.21 1.33 ± 0.31 
Urea (umol/L) 
FOR 9.08 ± 2.07 9.08 ± 2.08 8.93 ± 1.87 9.97 ± 1.69 
AF 9.8 ± 1.79 10.5 ± 2.82 10.0 ± 1.43 10.0 ± 1.70 
Uric Acid (umol/L) 
FOR 2.62 ± 1.25 2.37 ± 0.88 2.17 ± 0.90 2.19 ± 0.85 
AF 1.92 ± 0.78 2.02 ± 1.57 1.97 ± 1.19 1.75 ± 0.97 
VitdA (ng/mL) 
FOR 42.2 ± 14.4 45.7 ± 16.2 48.6 ± 16.1 52.7 ± 20.3 
AF 48.6 ± 27.7 52.5 ± 21.4 52.6 ± 20.5 55.1 ± 26.4 
GDF-15 (pg/mL) 
FOR 571 ± 262 514 ± 266 457 ± 243 466 ± 220 
AF 510 ± 230 474 ± 255 490 ± 207 482 ± 212 
FT3 (pg/dL) 
FOR 3.62 ± 0.79 3.57 ± 0.79 3.45 ± 0.62 3.57 ± 0.61 
AF 4.49 ± 1.78 4.57 ± 1.91 4.13 ± 0.85 4.25 ± 1.11 
FT4 (ng/mL) 
FOR 0.92 ± 0.32 0.94 ± 0.31 0.89 ± 0.27 1.04 ± 0.48 
AF 1.46 ± 1.05 1.22 ± 0.80 1.00 ± 0.39 1.16 ± 0.46 
TotT3 (ng/dL) 
FOR 40.2 ± 3.21 40.4 ± 3.51 39.9 ± 4.24 40.9 ± 5.19 
AF 42.0 ± 5.06 41.1 ± 4.42 41.3 ± 4.70 44.6 ± 6.66 
TotT4 (ug/dL) 
FOR 35.5 ± 9.73 40.4 ± 11.8 39.9 ± 9.55 40.9 ± 6.25 
AF 37.6 ± 8.29 42.6 ± 7.41 42.0 ± 9.52 42.3 ± 16.2 
TSH (ulU/mL) 
FOR 5.50 ± 1.08 5.75 ± 0.88 6.20 ± 1.48 5.44 ± 0.97 
AF 4.81 ± 0.96 5.78 ± 1.45 5.46 ± 0.78 5.77 ± 1.29 
TU (%) 
FOR 314 ± 55 331 ± 61 359 ± 79 308 ± 73 
AF 307 ± 74 317 ± 44 327 ± 62 349 ± 86 
Cortisol (ug/dL) 
FOR 13.4 ± 3.71 13.7 ± 2.52 11.2 ± 2.56 13.1 ± 4.01 
AF 15.0 ± 4.80 13.0 ± 4.64 14.4 ± 5.2 13.3 ± 4.2 
Testosterone (ng/dL) 
FOR 5.98 ± 3.88 5.96 ± 3.94 4.95 ± 2.61 5.31 ± 2.97 
AF 5.00 ± 3.76 5.30 ± 3.89 5.11 ± 3.62 5.07 ± 3.75 
Testosterone:cortisol 
ratio (ng/dL) 
FOR 0.48 ± 0.35 0.46 ± 0.33 0.47 ± 0.26 0.45 ± 0.26 
AF 0.39 ± 0.30 0.45 ± 0.37 0.42 ± 0.32 0.44 ± 0.33 
DHEA-S (ug/dL) 
FOR 210 ± 59.3 221 ± 76.0 208 ± 57.6 207 ± 63.5 
AF 251 ± 86.4 275 ± 163 267 ± 109 261 ± 103.9 
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hGH (ng/dL) 
FOR 2.87 ± 3.31 79 ± 1.04 3.18 ± 3.60 1.41 ± 2.19 
AF 0.72 ± 1.44 2.09 ± 5.33 2.45 ± 6.44 2.45 ± 6.59 
Creatinine (umol/L) 
FOR 84.6 ± 9.01 86.1 ± 7.09 87.5 ± 8.40 83.8 ± 8.86 
AF 76.3 ± 14.0 83.6 ± 12.0 83.6 ± 13.4 87.8 ± 13.9 
CRP (mg/L) 
FOR 0.98 ± 0.02 0.98 ± 0.01 0.98 ± 0.01 0.91 ± 0.25 
AF 0.95 ± 0.10 0.92 ± 0.17 0.94 ± 0.12 0.93 ± 0.16 
IL-6 (pg/dL) 
FOR 1.08 ± 0.45 0.93 ± 0.28 1.01 ± 0.30 0.88 ± 0.35 
AF 1.20 ± 0.82 1.39 ± 1.96 1.16 ± 1.06 1.02 ± 0.66 
LDH (U/L) 
FOR 179 ± 36.3 181.9 ± 38.0 171.6 ± 18.7 159.7 ± 12.2 
AF 171 ± 41.6 175 ± 24.9 179 ± 27.8 194 ± 33 
NormTr: normal training period, HVTr: high-volume training period, TapTr: taper training 
period, TIBC: total iron-binding capacity, UIBC: Unsaturated iron-binding capacity, VitdA: 
vitamin D (total 25(OH)D), GDF15: growth differentiation factor-15, FT3: free 
triiodothyronine, FT4: free thyroxine, TotT3: total triiodothyronine, TotT4: total thyroxine, 
TSH: thyroid stimulating hormone, TU: thyroid uptake, DHEA-S: dehydroepiandrosterone 
sulphate, hGH: human growth hormone, CRP: C-reactive protein, IL-6: interleukin-6, LDH: 
lactate dehydrogenase 
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